Buy The Ordinary Niacinamide 10% + Zinc 1% 30ml in Sri Lanka. Powerful serum for blemish control, oil regulation, and refined skin texture. Best for oily, acne-prone skin. Helps reduce pores and balance sebum production.
Rs. 5,280.00 Original price was: Rs. 5,280.00.Rs. 4,250.00Current price is: Rs. 4,250.00.
-20%
Buy The Ordinary Niacinamide 10% + Zinc 1% 30ml in Sri Lanka. Powerful serum for blemish control, oil regulation, and refined skin texture. Best for oily, acne-prone skin. Helps reduce pores and balance sebum production.
Say goodbye to blemishes and oily skin with The Ordinary Niacinamide 10% + Zinc 1% Serum – 30ml, one of the most trusted skincare solutions globally. This high-strength vitamin and mineral formula is designed to visibly reduce the appearance of skin blemishes, congestion, and sebum activity.
Perfect for acne-prone and oily skin types, this serum combines 10% Niacinamide (Vitamin B3) with 1% Zinc PCA, helping to tighten pores, even out skin tone, and minimize breakouts. Its lightweight, water-based formula absorbs quickly and layers perfectly under other skincare or makeup.
Whether you’re tackling hormonal acne, enlarged pores, or uneven skin texture, this is your go-to solution. Loved by thousands worldwide and now available in Sri Lanka, this serum will leave your skin smooth, clear, and balanced.
🔬 Reduces blemishes, acne, and skin congestion
💧 Controls excess oil and regulates sebum production
🌿 Refines pore appearance and smooths skin texture
⚖️ Balances uneven skin tone and brightens complexion
🧴 Lightweight, fast-absorbing, and non-comedogenic
🌍 Suitable for men and women with oily to combination skin
Apply a few drops to your entire face in the morning and evening before heavier creams.
Use daily for best results.
Avoid using with Vitamin C (Ascorbic Acid) products in the same routine.
Niacinamide 10% – Anti-inflammatory & brightening
Zinc PCA 1% – Sebum-regulating & calming
Only logged in customers who have purchased this product may leave a review.
WhatsApp us
There are no reviews yet.